[1]
2026. Repurposing of Ribavirin for the treatment of anticancer by using in silico molecular docking. International Journal of Research in Pharmaceutical Sciences and Technology. 9, 3 (Aug. 2026). DOI:https://doi.org/10.33974/x61ntj86.